Taryhe tumour markers carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), TPS, CA 19-9, CA 50 and CA 242 were analysed in serum from 203 potentially curable colorectal cancer patients. The levels of all markers increased with increasing tumour stage, and all markers correlated with survival. Multivariate analyses indicated that the Dukes stage had the best prognostic explanatory power, followed by TPA. In the subset of 166 potentially cured patients, the prognostic information by the markers was substantially reduced. We conclude that preoperative serum tumour marker measurements have the potential to aid therapy selection, but also that their clinical usefiulness is not immediately apparent. (Koprowski et al., 1979; Holmgren et al., 1984) . However, these new generation tumour markers have not given improved predictive information as expected (Holmgren et al., 1984; Kuusela et al., 1984; Gupta et al., 1985; Cangemi et al., 1987; Putzki et al., 1987; Johansson et al., 1991) .
The Dukes classification, although known only postoperatively, constitutes the best-known marker for staging and prognosis in colorectal cancer (Jass et al., 1986 (Dukes' stage C), the overall 5 year survival rate reaches only about 70% and 45% respectively. As additional treatment, possibly initiated early perioperatively, has been shown in recent studies (Moertel et al., 1990) to increase the overall survival rate, there is a need to select tools superior to but also available earlier than the Dukes stage.
The use of several serum tumour markers in colorectal cancer has been proposed with this intention (Moore et al., 1990) . Using a first generation of tumour markers, CEA (carcinoembryonic antigen) and TPA (tissue polypeptide antigen), a correlation between the preoperative serum level and survival has been demonstrated. Some studies have also shown that CEA or TPA provides information additional to Dukes' stage (StAhle et al., 1988a; Chu et al., 1991) , while this has not been demonstrated in other studies (Lewi et al., 1984; Moertel et al., 1986) . New antigens, such as CA 50 and CA 19-9, may provide further prognostic information (Koprowski et al., 1979; Holmgren et al., 1984) . However, these new generation tumour markers have not given improved predictive information as expected (Holmgren et al., 1984; Kuusela et al., 1984; Gupta et al., 1985; Cangemi et al., 1987; Putzki et al., 1987; Johansson et al., 1991) .
In previous studies from our group, the preoperative serum levels of three tumour markers, CEA, TPA and CA 50, provided prognostic information for rectal cancer (Stihle et al., 1988b) . The best combination of these tumour markers together with polyploid tumour growth gave, from a statistical point of view, preoperative prognostic information of the same order as that of the Dukes stage post-operatively. Post-operatively, the serum markers improved the prognostic pedictability of Dukes' stage. The aim of this study was to evaluate the same markers in independent material, including also colon cancer. In addition, CA 19-9 and two more recently reported markers, CA 242 (Nilsson et al., 1992) (27) 7 (20) 8 (23) 5 (14) 13 (37) 2 (6) 2 (6) B 87 45 (52) 51 (59) 15 (17) 40 (46) 19 (22) 28 (32) 11 (13) CEA/CA 19-9/TPA) markers reduced the proportion of potentially cured patients demonstrating elevated tumour marker levels (12% and 7% respectively) (Table II) .
Twnour mrarker levels and prognosis ofpotentially curable patients As continuous variables, all markers were strongly correlated with survival. The strongest significance was seen for TPA (Table III) . When categorised into quartiles, the RH (relative hazard) of the highest quartile was always significantly elevated compared with the first quartile. Moreover, the RH was significantly higher for CEA and TPS in the third quartile and for CA 50 in the second quartile than in the first quartile (Table IV) .
In multivariate analyses of the tumour markers, in logarithmic form, TPA was the most important variable. 
Disc_m
Every tested serum marker gave prognostic information in the group of patients of interest for pre-or peroperatively initiated additional treatment, i.e. patients in whom major surgery with curative intent was planned, revealing their possible importance for the selection of additional treatment. Also, in the group of patients of interest for prolonged post-operative adjuvant treatment, i.e. potentially cured patients (Dukes' stages A-C), the markers gave prognostic information. However, only some of them then kept their independent prognostic information, and without being highly significant.
We could confirm the potential value of the tumour markers CEA, CA 50 and TPA both for staging and for prediction of survival, which we previously reported in a separate study on rectal cancer only (Stihle et al., 1988ab, 1989 . We also found that the three other tumour markers, CA 19-9, CA 242 and TPS, can be used for the same purposes. However, the ability to predict either tumour stage or prognosis using these new markers did not exceed that of the oler ones. The prognostic information of the best tumour marker, TPA, or 
